by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Among the many peptides under active investigation, PE-22-28 stands out for its unique properties and versatile research applications. Originally studied for its effects on TREK-1 inhibitor, researchers have since discovered connections to antidepressant,...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Dihexa (Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)) has emerged as one of the most studied peptides in modern biomedical research. With its modified hexapeptide structure, this compound has attracted attention from researchers worldwide for its potential...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
In the ever-expanding landscape of peptide research, Semax occupies a notable position. This 7 amino acids compound has been the subject of numerous studies investigating its role in BDNF increase and ACTH analog. This article provides a detailed overview of current...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Selank, also known as Selank Heptapeptide, is a 7 amino acids peptide that has garnered significant attention in the research community. Studies have explored its potential in BDNF modulation, tuftsin analog, and related fields, yielding a growing body of evidence...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
The scientific community’s interest in PE-22-28 (Spadin Analog PE-22-28) has grown steadily over the past decade. Composed of 7 amino acids, this peptide has demonstrated notable effects in preclinical models related to cognitive function and rapid onset. Here,...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Among the many peptides under active investigation, Dihexa stands out for its unique properties and versatile research applications. Originally studied for its effects on memory enhancement, researchers have since discovered connections to Alzheimer research,...
